Mycobacterium bovis BCG immunization induces protective immunity against nine different Mycobacterium tuberculosis strains in mice

Infection and Immunity

Volumn 76, Issue 11, 2008, Pages 5173-5180

  Bo, Young Jeon ^a,c   Derrick, Steven C ^a   Lim, JaeHyun ^a   Kolibab, Kristopher ^a   Dheenadhayalan, Veerabadran ^a,d   Yang, Amy Li ^a   Kreiswirth, Barry ^b   Morris, Sheldon L ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c Yonsei University College of Medicine   (South Korea)

^d Aeras Global TB Vaccine Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BCG VACCINATION; C57BL 6 MOUSE; COLONY FORMING UNIT; CONTROLLED STUDY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN; STRAIN DIFFERENCE;

ANIMALS; BCG VACCINE; INFLAMMATION; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 55849132143     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00019-08     Document Type: Article

References (42)

1. Abebe, F., and G. Bjune. 2006. The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guerin (BCG) vaccines: is there a link? Clin. Exp. Immunol. 145:389-397.
2. Anh, D. D., M. W. Borgdorff, L. N. Van, N. T. Lan, T. van Gorkom, K. Kremer, and D. van Soolingen. 2000. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg. Infect. Dis. 6:302-305.
3. Bifani, P., B. Mathena, N. Kurepina, and B. N. Kreiswirth. 2002. The global dissemination of the W family of Mycobacterium tuberculosis strains. Trends Microbiol. 10:45-52.
4. Brewer, T. F. 2000. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin. Infect. Dis. 31:S64-S67.
5. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271:698-702.
6. Delogu, G., A. Li, C. Repique, F. Collins, and S. L. Morris. 2002. DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis. Infect. Immun. 70:292-302.
7. Derrick, S. C., A. L. Yang, and S. L. Morris. 2004. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 23:780-789.
8. Derrick, S. C., C. Repique, P. Snoy, A. L. Yang, and S. L. Morris. 2004. Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis. Infect. Immun. 72:1685-1692.
9. Dormans, J., M. Burger, D. Aguilar, R. Hernandez-Pando, K. Kremer, P. Roholl, S. M. Arend, and D. van Soolingen. 2004. Correlation of virulence, lung pathology, bacterial load, and delayed-type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clin. Exp. Immunol. 137:460-468.
10. Dunn, P. L., and R. J. North. 1995. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strain according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect. Immun. 63:3428-3437.
11. Fine, P. E. 2001. BCG: the challenge continues. Scand. J. Infect. Dis. 33:243-245.
12. Glynn, J. R., J. Whitely, P. J. Bifani, K. Kremer, and D. van Soolingen. 2002. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systemic review. Emerg. Infect. Dis. 8:843-849.
13. Gutacker, M., B. Mathena, H. Soini, E. Shashkina, B. N. Kreiswirth, E. A. Graviss, and J. M. Musser. 2006. Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J. Infect. Dis. 193:121-128.
14. Hanekom, M., G. D. van der Spuy, E. Streicher, S. L. Ndabambi, C. R. E. McEvoy, M. Kidd, N. Beyers, T. C. Victor, P. D. van Helden, and R. M. Warren. 2007. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family was associated with an increased ability to spread and cause disease. J. Clin. Microbiol. 45:1483-1490.
15. Hermans, P. W., M. F. Messadi, H. Guebrexabher, D. van Soolingen, P. E. de Haas, H. Heersma, H. de Neeling, A. Ayoub, F. Portaels, D. Frommel, M. Zribi, and J. D. A. van Embden. 1995. Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and the Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J. Infect. Dis. 171:1504-1513.
16. Hinchey, J., S. Lee, B. Y. Jeon, R. J. Basaraba, M. M. Venkataswamy, B. Chen, J. Chan, M. Braunstein, I. M. Orme, S. C. Derrick, S. L. Morris, W. R. Jacobs, Jr., and S. A. Porcelli. 2007. Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J. Clin. Investig. 117:2279-2288.
17. Hirsh, A. E., A. G. Tsolaki, K. DeRiemer, M. W. Feldman, and P. M. Small. 2004. Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc. Natl. Acad. Sci. USA 101:4871-4876.
18. Kelley, C. L., and F. M. Collins. 1999. Growth of a highly virulent strain of Mycobacterium tuberculosis in mice of differing susceptibility to tuberculous challenge. Tuber. Lung Dis. 79:367-370.
19. Lopez, B., D. Aguilar, H. Orozco, M. Burger, C. Espitia, V. Ritacco, L. Barrera, K. Kremer, R. Hernandez-Pando, K. Huygen, and D. van Soolingen. 2003. A marked difference in the pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin. Exp. Immunol. 133:30-37.
20. Malik, A. N. J., and P. Godfrey-Fausett. 2005. Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease. Lancet Infect. Dis. 5:174-183.
21. Manabe, Y. C., A. M. Dannenberg, S. K. Tyagi, C. L. Hatem, M. Yoder, S. C. Woolwine, B. C. Zook, M. L. Pitt, and W. R. Bishai. 2003. Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis. Infect. Immun. 71:6004-6011.
22. Manca, C., L. Tsenova, C. E. Barry III, A. Bergtold, S. Freeman, P. A. J. Hackett, J. M. Musser, V. H. Freedman, and G. Kaplan. 1999. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J. Immunol. 162:6740-6746.
23. Manca, C., L. Tsenova, A. Bergtold, S. Freeman, M. Tovey, J. M. Musser, C. E. Barry, V. H. Freedman, and G. Kaplan. 2001. Virulence of a Mycobacterium tuberculosis isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN α/β. Proc. Natl. Acad. Sci. USA 98:5752-5757.
24. Mathema, B., N. Kurepina, P. Bifani, and B. N. Kreiswirth. 2006. Epidemiology of Mycobacterium tuberculosis: current insights. Clin. Microbiol. Rev. 19:658-685.
25. McShane, H. 2003. Susceptibility to tuberculosis - the importance of the pathogen as well as the host. Clin. Exp. Immunol. 133:20-21.
26. Milan, S. J., K. A. Hauge, N. E. Kurepina, K. H. Lofy, S. V. Goldberg, M. Narita, C. M. Nolan, P. D. McElroy, B. N. Kreiswirth, and G. A. Cangelosi. 2004. Expanded geographical distribution of the N family of Mycobacterium tuberculosis strains within the United States. J. Clin. Microbiol. 42:1064-1068.
27. North, R. J., L. Ryan, R. LaCourse, T. Mogues, and M. E. Goodrich. 1999. Growth rate of mycobacteria in mice as an unreliable indicator of mycobacterial virulence. Infect. Immun. 67:5483-5485.
28. Ordway, D., M. Henao-Temayo, M. Harton, G. Palanisamy, J. Troudt, C. Shanley, R. J. Basaraba, and I. M. Orme. 2007. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J. Immunol. 179:522-531.
29. Ordway, D. J., M. G. Sonnenberg, S. A. Donahue, J. T. Belisle, and I. M. Orme. 1995. Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice. Infect. Immun. 63:741-743.
30. Palanisamy, G. S., E. E. Smith, C. A. Shanley, D. J. Ordway, I. M. Orme, and R. J. Basaraba. 5 March 2008, posting date. Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model. Tuberculosis. doi:10.1016/j.tube.2007.12.003.
31. Repique, C. J., A. Li, F. M. Collins, and S. L. Morris. 2002. DNA immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge. Infect. Immun. 70:3318-3323.
32. Roring, S., A. Scott, D. Brittain, I. Walker, G. Hewinson, S. Neill, and R. Skuce. 2002. Development of variable-number tandem repeat typing of Mycobacterium bovis: comparison of results with those obtained by using existing exact tandem repeats and spoligotyping. J. Clin. Microbiol. 40:2126-2133.
33. Smittipat, N., P. Billamas, M. Palittapongarnpim, A. Thong-On, M. M. Temu, P. Thanakijcharoen, O. Karnkawinpong, and P. Palittapongarnpim. 2005. Polymorphism of variable-number repeats at multiple loci in Mycobacterium tuberculosis. J. Clin. Microbiol. 43:5034-5043.
34. Sreevatsan, S., X. Pan, K. E. Stockbauer, N. D. Connell, B. N. Kreiswirth, T. S. Whittam, and J. M. Musser. 1997. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc. Natl. Acad. Sci. USA 94:9869-9874.
35. Tsenova, L., E. Ellison, R. Harbacheuski, A. L. Moreira, N. Kurepina, M. B. Reed, B. Mathema, C. E. Barry, and G. Kaplan. 2005. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model is dependent on the phenolic glycolipid produced by the bacilli. J. Infect. Dis. 192:98-106.
36. Tsenova, L., R. Harbacheuski, N. Sung, E. Ellison, D. Fallows, and G. Kaplan. 2007. BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. Vaccine 25:5126-5132.
37. Valway, S. E., M. P. Sanchez, T. F. Shinnick, I. Orme, T. Agerton, D. Hoy, J. S. Jones, H. Westmoreland, and I. M. Onorato. 1998. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N. Engl. J. Med. 338:633-639.
38. van Soolingen, D., L. Quan, and P. E. de Han. 1995. Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J. Clin. Microbiol. 33:3234-3238.
39. Warren, R. M., T. C. Victor, E. M. Streicher, M. Richardson, N. Beyers, N. C. Gey van Pittius, and P. D. van Helden. 2004. Patients with active tuberculosis often have different strains in the same sputum specimen. Amer. J. Respir. Crit. Care Med. 165:610-614.
40. Wedlock, D. N., M. Denis, H. M. Vordermeier, R. G. Hewinson, and B. M. Buddle. 2007. Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFN-γ postvaccination, but induce similar levels of protection against bovine tuberculosis. Vet. Immunol. Immunopathol. 118:50-58.
41. World Health Organization. 2007. Tuberculosis fact sheet no.104. World Health Organization, Geneva, Switzerland. http://www.who.imt/mediacentre/ factssheets/fs104/en.
42. Wu, B., C. Huang, L. Garcia, A. Ponce de Leon, J. S. Osnorio, M. Bobadilladel-Valle, L. Ferreira, S. Canizales, P. Small, M. Kato-Maeda, A. M. Krensky, and C. Clayberger. 2007. Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guérin. Infect. Immun. 75:3658-3664.